Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

N-n-propylnorapomorphine

Known as: N-propylnorapomorphine, n-propylapomorphine, 6-propylnorapomorphine 
 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

Antiparkinson AgentsApomorphineDopamine Agonists
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors.
Dopaminergic signaling pathways have been extensively investigated using PET imaging, primarily with antagonist radioligands of D… Expand
  • figure 1
  • table I
  • figure 2
  • table II
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions
The actions on central dopamine (DA) mechanisms of raclopride, a new substituted benzamide, were studied by means of behavioural… Expand
  • figure 2
  • table 1
  • figure 3
  • figure 4
  • table 2
Is this relevant?
2003
2003
Kinetics of the uptake and distribution of the dopamine D(2,3) agonist (R)-N-[1-(11)C]n-propylnorapomorphine in brain of healthy and MPTP-treated Göttingen miniature pigs.
The binding of radioligand agonists to dopamine receptors in living brain can be informative about the abundance of receptors… Expand
Is this relevant?
2002
2002
Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G Protein
According to the ternary complex model of G-protein linkage to receptors, agonists increase the affinity of the receptors for the… Expand
Is this relevant?
1997
1997
Long-Term Effects of S(+)N-n-Propylnorapomorphine Compared with Typical and Atypical Antipsychotics: Differential Increases of Cerebrocortical D2-Like and Striatolimbic D4-Like Dopamine Receptors
Changes in D2-like dopamine (DA) receptor binding in rat brain regions were compared by quantitative in vitro receptor… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1990
Highly Cited
1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties.
The design, synthesis, and pharmacological properties of a novel type of 4-(1,2,5,6-tetrahydro-1-alkyl-3-pyridinyl)-2… Expand
Is this relevant?
1990
1990
In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine.
Cabergoline is a potent dopaminergic agent that interacts with agonists and antagonists of dopamine receptors in vitro. We… Expand
Is this relevant?
1989
1989
Kinetic properties of the in vivo accumulation of 3H-(−)-N-n-propylnorapomorphine in mouse brain
Summary(1) The influence of various dopamine (DA) receptor agonists and antagonists on the kinetic properties of the specific… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1989
1989
Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens
Injection of the dopamine (DA) agonist R-(-)-N-n-propylnorapomorphine (NPA; 5-40 micrograms) into anterior ventral striatal sites… Expand
Is this relevant?
1986
1986
Dopamine agonist treatment of schizophrenia with N-propylnorapomorphine.
We administered N-propylnorapomorphine, a potent aporphine-family dopamine (DA) agonist, to schizophrenic patients with active… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE